CD274 and cancer: However, restricting glutamine uptake by cancer cells increases PD-L1 expression through stimulation of Ca2+/NF-κB signaling, resulting in diminished anticancer activity of T cells, which may be successfully eliminated by anti-PD-L1 therapy [6].